Literature DB >> 27564971

Beta Testing a Novel Smartphone Application to Improve Medication Adherence.

Erin Sarzynski1,2, Brian Decker3, Aaron Thul3, David Weismantel1,4, Ronald Melaragni5, Elizabeth Cholakis6, Megha Tewari1,6, Kristy Beckholt1,6, Michael Zaroukian6,7, Angie C Kennedy8, Charles Given1,2.   

Abstract

BACKGROUND: We developed and beta-tested a patient-centered medication management application, PresRx optical character recognition (OCR), a mobile health (m-health) tool that auto-populates drug name and dosing instructions directly from patients' medication labels by OCR.
MATERIALS AND METHODS: We employed a single-subject design study to evaluate PresRx OCR for three outcomes: (1) accuracy of auto-populated medication dosing instructions, (2) acceptability of the user interface, and (3) patients' adherence to chronic medications.
RESULTS: Eight patients beta-tested PresRx OCR. Five patients used the software for ≥6 months, and four completed exit interviews (n = 4 completers). At baseline, patients used 3.4 chronic prescription medications and exhibited moderate-to-high adherence rates. Accuracy of auto-populated information by OCR was 95% for drug name, 98% for dose, and 96% for frequency. Study completers rated PresRx OCR 74 on the System Usability Scale, where scores ≥70 indicate an acceptable user interface (scale 0-100). Adherence rates measured by PresRx OCR were high during the first month of app use (93%), but waned midway through the 6-month testing period (78%). Compared with pharmacy fill rates, PresRx OCR underestimated adherence among completers by 3%, while it overestimated adherence among noncompleters by 8%. DISCUSSION: Results suggest smartphone applications supporting medication management are feasible and accurately assess adherence compared with objective measures. Future efforts to improve medication-taking behavior using m-health tools should target specific patient populations and leverage common application programming interfaces to promote generalizability.
CONCLUSIONS: Our medication management application PresRx OCR is innovative, acceptable for patient use, and accurately tracks medication adherence.

Entities:  

Keywords:  adherence; health information technology; m-health; medication management; smartphone

Mesh:

Year:  2016        PMID: 27564971     DOI: 10.1089/tmj.2016.0100

Source DB:  PubMed          Journal:  Telemed J E Health        ISSN: 1530-5627            Impact factor:   3.536


  5 in total

1.  Mobile Application to Promote Adherence to Oral Chemotherapy and Symptom Management: A Protocol for Design and Development.

Authors:  Joel Nathan Fishbein; Lauren Ellen Nisotel; James John MacDonald; Nicole Amoyal Pensak; Jamie Michele Jacobs; Clare Flanagan; Kamal Jethwani; Joseph Andrew Greer
Journal:  JMIR Res Protoc       Date:  2017-04-20

Review 2.  A Scoping Review of the Quality and the Design of Evaluations of Mobile Health, Telehealth, Smart Pump and Monitoring Technologies Performed in a Pharmacy-Related Setting.

Authors:  Darrin Baines; Imandeep K Gahir; Afthab Hussain; Amir J Khan; Philip Schneider; Syed S Hasan; Zaheer-Ud-Din Babar
Journal:  Front Pharmacol       Date:  2018-07-26       Impact factor: 5.810

Review 3.  Technology Acceptance in Mobile Health: Scoping Review of Definitions, Models, and Measurement.

Authors:  Camille Nadal; Corina Sas; Gavin Doherty
Journal:  J Med Internet Res       Date:  2020-07-06       Impact factor: 5.428

4.  A Mobile App (mHeart) to Detect Medication Nonadherence in the Heart Transplant Population: Validation Study.

Authors:  Eulalia Roig; Sonia Mirabet; Mar Gomis-Pastor; Jan T De Pourcq; Irene Conejo; Anna Feliu; Vicens Brossa; Laura Lopez; Andreu Ferrero-Gregori; Anna Barata; M Antonia Mangues
Journal:  JMIR Mhealth Uhealth       Date:  2020-02-04       Impact factor: 4.773

5.  Rationale design and efficacy of a smartphone application for improving self-awareness of adherence to edoxaban treatment: study protocol for a randomised controlled trial (adhere app).

Authors:  In-Cheol Kim; Ji Hyun Lee; Dong-Ju Choi; Sung-Ji Park; Ju-Hee Lee; Sang Min Park; Mina Kim; Hack-Lyoung Kim; Sunki Lee; In Jai Kim; Seonghoon Choi; Jaehun Bang; Bilal Ali; Musarrat Hussain; Taqdir Ali; Sungyoung Lee
Journal:  BMJ Open       Date:  2022-04-27       Impact factor: 3.006

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.